当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析

瑞普生物

(300119)

  

流通市值:69.51亿  总市值:96.66亿
流通股本:3.35亿   总股本:4.66亿

瑞普生物(300119)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.64亿元,每股收益0.53元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益495784.77万元,未分配利润173285.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产743578.46万元,负债247793.69万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,746,806,365.211,099,038,124.02533,199,134.682,248,962,053.98
营业总成本1,466,821,630.31930,264,855.6435,867,665.21,874,332,565.39
营业利润304,079,230.76189,079,930.86105,375,441.99565,230,235.97
利润总额302,288,879.01188,310,170.37105,078,491.84566,680,053.37
净利润264,182,740.83167,808,511.4493,504,682.67511,016,725.18
其他综合收益----
综合收益总额264,182,740.83167,808,511.4493,504,682.67511,016,725.18
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,348,371,664.993,074,979,408.233,378,521,402.173,263,327,707.08
非流动资产合计4,087,412,944.914,120,857,505.473,285,958,772.623,332,613,794
资产总计7,435,784,609.97,195,836,913.76,664,480,174.796,595,941,501.08
流动负债合计1,741,306,167.41,703,685,671.391,230,804,815.21,344,905,393.37
非流动负债合计736,630,765.67609,177,592.69548,728,975.84446,150,180.04
负债合计2,477,936,933.072,312,863,264.081,779,533,791.041,791,055,573.41
归属于母公司股东权益合计4,549,883,109.644,463,681,060.074,570,430,994.594,496,304,113.26
股东权益合计4,957,847,676.834,882,973,649.624,884,946,383.754,804,885,927.67
负债和股东权益合计7,435,784,609.97,195,836,913.76,664,480,174.796,595,941,501.08
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,778,174,197.981,173,987,012.83547,363,142.822,138,323,520.77
经营活动现金流出小计1,422,050,640.26978,148,149.54458,227,213.591,760,127,192.17
经营活动产生的现金流量净额356,123,557.72195,838,863.2989,135,929.23378,196,328.6
投资活动现金流入小计2,604,449,087.072,036,456,932.171,008,289,220.33,817,291,917.93
投资活动现金流出小计2,835,676,691.121,963,307,191.36833,554,625.023,978,266,527.07
投资活动产生的现金流量净额-231,227,604.0573,149,740.81174,734,595.28-160,974,609.14
筹资活动现金流入小计713,050,000579,000,000204,000,000725,107,254.95
筹资活动现金流出小计823,448,004.05790,957,215.44188,013,503.58997,568,243.13
筹资活动产生的现金流量净额-110,398,004.05-211,957,215.4415,986,496.42-272,460,988.18
汇率变动对现金及现金等价物的影响392,159.94355,470.6959,671.0364,250.48
现金及现金等价物净增加额14,890,109.5657,386,859.35279,916,691.96-55,175,018.24
期末现金及现金等价物余额336,420,024.26378,916,774.05601,446,606.66321,529,914.7
最新报告期:2024-11-22
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国信证券李瑞楠,鲁家瑞1.121.341.392024-11-22
中信证券盛夏,彭家乐0.810.971.182024-11-08
华安证券王莺,万定宇1.001.271.492024-11-03
民生证券徐菁0.760.991.142024-11-01
国海证券熊子兴,程一胜0.841.011.192024-11-01
TOP↑